$
21.64
+$0.00
As of February 13, 2026
· USD
Open
$21.64
High
$21.64
Low
$21.64
Prev Close
$21.64
Volume
35.02M
52-Wk High
$23.57
52-Wk Low
$6.38
Market Cap
$2.12B
P/E
-1082.00
EPS
$-0.02
About
Avadel Pharmaceuticals plc is a biopharmaceutical firm primarily conducting its operations within the United States. The company's flagship investigational drug, FT218, a specialized compound of sodium oxybate, is curren...See more
Ticker
AVDL
Exchange
NASDAQ Global Market
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Gregory J. Divis Jr.
Website
https://investor.alkermes.com/news-releases/news-release-details/alkermes-plc-completes-acquisition-avadel-pharmaceuticals-plc ↗
Address
10 Earlsfort Terrace, Dublin, 2, IE
Phone
353 1 901 5201
Market Cap
$2.12B
Financial Performance
| Net sales | |||||
| Gross margin | |||||
| Net income |
In the news